Institution
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Also known as: Lurie Cancer Center · Lurie Comprehensive Cancer Center · Robert H. Lurie Cancer Center · Robert H. Lurie Comprehensive Cancer Center
- 33running trials
- 14closed trials
- 9,708publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Active, not recruiting
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Active, not recruiting
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Active, not recruiting
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
Recruiting
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Acute myeloid leukaemia2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Endometrial cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Sarcoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Follicular lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Prostate cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Uterine fibroids1 recruiting
Closed trials
Completed
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Terminated
Terminated
Terminated
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
Completed
Completed
Completed
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer
Completed
Completed
Completed
Completed
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Completed
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Registry name variants (14)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois 60611
15 trials
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois 60611
8 trials
Robert H Lurie Comprehensive Cancer Center Northwestern University
Chicago, Illinois 60611
5 trials
Northwestern University, Robert H Lurie Comprehensive Cancer Center
Chicago, Illinois 60611
4 trials
Robert H Lurie Comprehensive Cancer Center
Chicago, Illinois 60611
3 trials
Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois 63110
2 trials
NCT06925542A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Contact: Kaitlin King
NCT05303519SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Contact: Laura Sharp
Northwestern University - Lurie Comprehensive Cancer Center
Chicago, Illinois 60611
2 trials
Robert H Lurie Cancer Center
Chicago, Illinois 60611
2 trials
NCT06116110Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Contact: Chiena Whitt
NCT04792489DALY II USA/ MB-CART2019.1 for DLBCL
Contact: Reem Karmali, MD
Lurie Cancer Center - Northwestern University
Chicago, Illinois 60611
1 trial
Northwestern University- Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois 60610
1 trial
Northwestern University- Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois 60611-3015
1 trial
Northwestern University - Robert H. Lurie Comprehensive Cancer Center - NMDTI
Chicago, Illinois 60611
1 trial
Northwestern University - Robert H. Lurie Comprehensive Cancer Center (Site 0018)
Chicago, Illinois 60611
1 trial
Northwestern University - Robert H. Lurie Comprehensive Cancer Center (Site 0130)
Chicago, Illinois 60611
1 trial
Contact: Study Coordinator
Conditions
Diseases this institution publishes on or runs trials for.
- Glioblastoma46 works · 3 trials
- Metastatic breast cancer13 works · 4 trials
- Mantle cell lymphoma5 works · 1 trial
Institution data: ROR 02p4far57 (CC0-1.0)Updated 15 Nov 2026